RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Adebayo Oyekan to Kidney

This is a "connection" page, showing publications Adebayo Oyekan has written about Kidney.
Connection Strength

3.678
  1. Alshaman R, Truong L, Oyekan A. Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury. Clin Exp Pharmacol Physiol. 2016 Nov; 43(11):1087-1096.
    View in: PubMed
    Score: 0.492
  2. Dallatu MK, Choi M, Oyekan AO. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal. J Hypertens. 2013 Oct; 31(10):2043-9.
    View in: PubMed
    Score: 0.397
  3. Fidelis P, Wilson L, Thomas K, Villalobos M, Oyekan AO. Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. Exp Biol Med (Maywood). 2010 Nov; 235(11):1365-74.
    View in: PubMed
    Score: 0.323
  4. Newaz M, Yousefipour Z, Oyekan A. Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure. Ren Fail. 2010 Jan; 32(3):384-90.
    View in: PubMed
    Score: 0.306
  5. Newaz M, Ranganna K, Truong LD, Oyekan A. Effect of peroxisome proliferator-activated receptor-alpha siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet. J Hypertens. 2009 Nov; 27(11):2223-31.
    View in: PubMed
    Score: 0.303
  6. Williams J, Bogwu J, Oyekan A. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J Hypertens. 2006 Jul; 24(7):1429-36.
    View in: PubMed
    Score: 0.240
  7. Edosuyi O, Igbe I, Oyekan A. Fumarate and its downstream signalling pathways in the cardiorenal system: Recent insights and novel expositions in the etiology of hypertension. Eur J Pharmacol. 2023 Dec 15; 961:176186.
    View in: PubMed
    Score: 0.200
  8. Ogungbade GO, Akinsanmi LA, Jiang H, Oyekan AO. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat. Am J Physiol Renal Physiol. 2003 Nov; 285(5):F955-64.
    View in: PubMed
    Score: 0.196
  9. Edosuyi O, Adesuyi A, Choi M, Igbe I, Oyekan A. Malate reduced blood pressure and exerted differential effects on renal hemodynamics; role of the nitric oxide system and renal epithelial sodium channels (ENaC). Eur J Pharmacol. 2023 Jan 05; 938:175441.
    View in: PubMed
    Score: 0.187
  10. Hercule H, Oyekan A. Renal cytochrome p450 oxygenases and preglomerular vascular response to arachidonic acid and endothelin-1 following ischemia/reperfusion. J Pharmacol Exp Ther. 2002 Aug; 302(2):717-24.
    View in: PubMed
    Score: 0.183
  11. Newaz MA, Oyekan AO. Contribution of renal oxygenases to glycerol-induced acute renal failure in the rat. J Cardiovasc Pharmacol. 2002 Jun; 39(6):834-41.
    View in: PubMed
    Score: 0.181
  12. Edosuyi O, Choi M, Igbe I, Oyekan A. Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens. 2021 Aug 18; 43(6):555-564.
    View in: PubMed
    Score: 0.168
  13. Oyekan AO. Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat. Clin Exp Pharmacol Physiol. 2000 Aug; 27(8):581-6.
    View in: PubMed
    Score: 0.159
  14. Yousefipour Z, Oyekan A, Newaz M. Role of G protein-coupled receptor kinase-2 in peroxisome proliferator-activated receptor gamma-mediated modulation of blood pressure and renal vascular reactivity in SHR. Am J Nephrol. 2009; 30(3):201-8.
    View in: PubMed
    Score: 0.073
  15. Blanton A, Nsaif R, Hercule H, Oyekan A. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. J Hypertens. 2006 Sep; 24(9):1865-72.
    View in: PubMed
    Score: 0.061
  16. Newaz M, Yousefipour Z, Oyekan A. Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure. Pharmacol Res. 2006 Sep; 54(3):234-40.
    View in: PubMed
    Score: 0.060
  17. Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, Mu W, Oyekan AO, Johnson RJ. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int. 2005 Nov; 68(5):2154-63.
    View in: PubMed
    Score: 0.057
  18. Newaz MA, Yousefipour Z, Hercule H, Truong L, Oyekan A. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection. Clin Exp Hypertens. 2003 Aug; 25(6):335-47.
    View in: PubMed
    Score: 0.049
  19. Newaz MA, Yousefipour Z, Oyekan A. Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension. Blood Press. 2002; 11(2):110-5.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support